Activity ID



December 23, 2023

Format Type


CME Credit




CME Provider: JAMA Network Open

Description of CME Course

We now recognize that a greatly expanded capacity for mass screening will be essential to managing life and economic activity in an ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. We also know that identifying asymptomatic people with acute SARS-CoV-2 infection requires frequent testing and results that are available quickly enough to act. Rapid antigen tests that can do this have been developed and their production is increasing, but the scale of capacity needed for effective screening is truly daunting. For context, consider that the National Institutes of Health estimates that the US could achieve capacity to run 42 million tests per week in 2021.2 Then consider that there are roughly 50 million children attending US public schools alone; even once-weekly screening in these schools would consume all the diagnostic and screening tests we can produce.


1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To identify the key insights or developments described in this article


Infectious Diseases, Coronavirus (COVID19), Pulmonary Medicine


Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit



View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.